NSEOutcome of Board MeetingFundraise26 Oct 2026
Wealth First Portfolio Managers Limited
Outcome of Board Meeting
Wealth First Portfolio Managers Limited has informed the Exchange regarding Outcome of Board Meeting held on October 26, 2026, where the Board approved the execution of Share Purchase Agreement to acquire 51.00% of the total outstanding equity share capital of Wealth First Advisors Private Limited, and the issue of Equity Shares under Preferential Issue for Consideration other than Cash.
BSECompany UpdateFundraise25 Oct 2026
Crescentis Capital Ltd
Prior Intimation of the meeting of the Fung Raising Committee of the Board of Director to be held on 29th October, 2026 (Thursday) of the Company for the Rights Issue
Crescentis Capital Ltd has scheduled a meeting of its Fund-Raising Committee to consider the terms and conditions of a proposed rights issue of up to Rs 80 crores.
BSECompany UpdateFundraise25 Oct 2026
Bharat Parenterals Ltd
Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026.
Bharat Parenterals Ltd has announced the approval of a preferential issue through an Extra-Ordinary General Meeting (EGM) held on October 23, 2026. The company submitted revised voting results to rectify an inadvertent categorisation error in the voting-results statement. The revised voting results were placed on the company's website and on the website of National Securities Depository Limited.
BSECompany UpdateFundraise25 Oct 2026
Fratelli Vineyards Ltd
With reference to the Board meeting held on 1st October, 2026, approving Rights issue of equity shares to the eligible shareholders , we would like to inform that a meeting of Rights Issue committee of the Board of Directors is scheduled to be held on Monday, October 26, 2026.
Fratelli Vineyards Ltd has announced a meeting of the Rights Issue Committee to be held on October 26, 2026, to consider the issue price, entitlement ratio, and other modalities related to the proposed rights issue of up to Rs. 30 crores.
BSEBoard MeetingFundraise24 Oct 2026
Popees Baby Care India Ltd
Pursuant to Reg. 30 of SEBI (LODR) Regulations, 2015, the Board at its meeting held on 24.10.2026 approved: (1) issue of up to 2,58,89,023 equity shares and (2) up to 98,31,758 convertible warrants at Rs. 142.44 each, on preferential basis, for consideration other than cash (share swap with shareholders of Popees Baby Care Products Ltd); (3) Relevant Date 11.11.2026; (4) Notice of 1st EGM on 12.12.2026 at 12:00 P.M. via VC/OAVM; (5) appointment of ....
Popees Baby Care India Ltd has approved the issuance of up to 2,58,89,023 equity shares and up to 98,31,758 convertible warrants at ₹142.44 each, on a preferential basis, for consideration other than cash (share swap with shareholders of Popees Baby Care Products Ltd). The company has also fixed November 11, 2026, as the Relevant Date for the Preferential Issue and scheduled an Extraordinary General Meeting on December 12, 2026.
NSEGeneral UpdatesFundraise24 Oct 2026
Reliance Industries Limited
General Updates
Reliance Industries Limited has announced the finalisation of the issue price for the Initial Public Offer (IPO) of its subsidiary Jio Platforms Limited at ₹1,119 per equity share. The IPO, which opened on October 21, 2026 and closed on October 23, 2026, was for up to 27 crore equity shares of face value ₹10 each.
BSECompany UpdateFundraise24 Oct 2026
Reliance Industries Ltd
JPL has today finalised the Issue Price at Rs. 1,119 per Equity Share and has also filed Prospectus dated October 24, 2026 with the Registrar of Companies, Gujarat at Ahmedabad.
Reliance Industries Ltd's subsidiary Jio Platforms Limited has finalized the issue price at ₹1,119 per equity share for its initial public offer, which was open for subscription from October 21 to October 23, 2026.
BSECompany UpdateFundraise24 Oct 2026
Panchsheel Organics Ltd
announcement under Regulation 30 (LODR)- meeting updates, approval received from Board of directors of the company passed through Resolution by circular for application National Stock Exchange(NSE) , Main board through direct listing route for listing its securities.
Panchsheel Organics Ltd has informed the BSE that its Board of Directors has approved making an application to the National Stock Exchange (NSE) for listing its securities on the NSE Main Board through the direct listing route.
BSECompany UpdateFundraise24 Oct 2026
Panchsheel Organics Ltd
Pursuant to Regulation-30 of the Listing Regulations , we wish to inform you that the Board Of Directors, by way of a circular resolution, dated 24th October 2026, has approved making an application to the National Stock Exchange of India(NSE) for the listing of the entire issued, subscribed and paid-up capital of the company on NSE Main Board under the direct Listing Route.
Panchsheel Organics Ltd has announced its intention to list on the National Stock Exchange (NSE) Main Board under the direct listing route, subject to regulatory approvals and compliance with applicable laws.
BSECompany UpdateFundraise24 Oct 2026
Goyal Associates Ltd
Raising of Funds through Right Issue
Goyal Associates Ltd has announced the approval of a rights issue of up to 7000 lakhs of equity shares, with the Board of Directors also approving the Draft Letter of Offer and the constitution of a Rights Issue Committee. Additionally, the company has announced the resignation of Mr. Vuppala Naga Malleswara Rao as a Director and the appointment of Mr. Ajay Solanki as the Chief Financial Officer on an additional-charge basis.
BSECompany UpdateFundraise24 Oct 2026
Arvaya Healthcare Ltd
Allotment of 38,71,854 fully paid Equity Shares of Rs.10/-each at an issue price of Rs.40/- per equity share including a premium of Rs.30/- per equity share aggregating to Rs. 15,48,74,160/- on a preferential allotment basis through private placement to the shareholders of Sushodha Institute of Gastroenterology Private Limited for a consideration other than cash on a share swap basis.
Arvaya Healthcare Ltd has allotted 38,71,854 fully paid equity shares to shareholders of Sushodha Institute of Gastroenterology Private Limited on a preferential basis at an issue price of Rs.40 per share, including a premium of Rs.30 per share, aggregating to Rs.15,48,74,160. The new shares will rank pari-passu with existing equity shares and will be locked-in for a specified period.
NSEShareholders meetingFundraise24 Oct 2026
Swaraj Suiting Limited
Shareholders meeting
Swaraj Suiting Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on October 24, 2026, where the company issued up to 35,00,000 equity shares and 17,00,000 convertible warrants on a preferential basis to identified non-promoter category persons.
BSEBoard MeetingFundraise24 Oct 2026
Arvaya Healthcare Ltd
Allotment of 38,71,854 (Thirty Eight Lakh Seventy One Thousand Eight Hundred Fifty Four) fully paid-up equity shares of face value of ?10/- (Rupees Ten Only) each ('Equity Shares') at an issue price of ?40/- (Rupees Forty Only) per Equity Share, including a premium of ?30/- (Rupees Thirty Only) per Equity Share, aggregating to ?15,48,74,160/- (Rupees Fifteen Crore Forty Eight Lakh Seventy Four Thousand One Hundred and Sixty Only), on a preferential ....
Arvaya Healthcare Ltd has allotted 38,71,854 equity shares at ₹40/- per share, including a premium of ₹30/- per share, aggregating to ₹15,48,74,160/-, on a preferential allotment basis to the shareholders of Sushodha Institute of Gastroenterology Private Limited (SIGPL) for consideration other than cash, on a share swap basis. The paid-up equity capital of the Company has increased from Rs. 48,02,18,570/- to Rs. 51,89,37,110/-.
BSEBoard MeetingFundraise24 Oct 2026
Goyal Associates Ltd
OUTCOME OF BOARD MEETING
Goyal Associates Ltd has announced the outcome of its board meeting, which included the approval of a rights issue of up to 7,000 lakhs of equity shares, the appointment of a rights issue committee, and the resignation of two directors, including the CFO.
BSECompany UpdateFundraise24 Oct 2026
Bharat Parenterals Ltd
Approval of Preferential Issue by shareholders of the company through EGM held on October 23, 2026.
Bharat Parenterals Ltd has announced that its shareholders have approved the issuance of equity shares on a preferential basis and making investments, giving loans, guarantees, and providing security in excess of limits specified under Section 186(2) of the Companies Act, 2013.
BSEAGM/EGMFundraise24 Oct 2026
Bharat Parenterals Ltd
Voting Results and Scrutinizer Report for the EGM held on October 23, 2026.
Bharat Parenterals Ltd has announced the voting results and scrutinizer report for its EGM held on October 23, 2026, where two resolutions were passed with requisite majority, including the issuance of equity shares on a preferential basis and making investments, giving loans, guarantees, and providing security in excess of limits specified under Section 186(2) of the Companies Act, 2013.
BSECompany UpdateFundraise24 Oct 2026
ACI Infocom Ltd
ACI Infocom Limited has informed the Exchange regarding the Allotment of 3,20,00,000 Equity shares and 20,70,00,000 Fully Convertible warrants on Preferential basis.
ACI Infocom Ltd has informed the exchange about the allotment of 3,20,00,000 equity shares and 20,70,00,000 fully convertible warrants on a preferential basis.
BSEGeneralFundraise24 Oct 2026
ACI Infocom Ltd
ACI Infocom Limited has informed the Exchange regarding the Outcome of the Board Meeting held on October 24, 2026 with respect to allotment of Equity shares and Fully Convertible Warrants.
ACI Infocom Ltd has informed the Exchange regarding the Outcome of the Board Meeting held on October 24, 2026, where the Preferential Allotment Committee approved the allotment of 3,20,00,000 Equity Shares and 20,70,00,000 Equity Warrants.
BSECompany UpdateFundraise24 Oct 2026
Sakuma Exports Ltd
REVISED OUTCOME OF BOARD MEETING HELD ON 23.10.2026.
Sakuma Exports Ltd has announced a revised outcome of its board meeting, including the issuance of up to 65 crore equity shares on a preferential basis at Rs. 1.66 per share, and the appointment of a scrutinizer for the Extra-Ordinary General Meeting.
NSEOutcome of Board MeetingFundraise24 Oct 2026
Sakuma Exports Limited
Outcome of Board Meeting
Sakuma Exports Limited has informed the Exchange regarding REVISED OUTCOME OF BOARD MEETING HELD ON 23.10.2026. The Board of Directors in its meeting held today i.e. 19th October 2026, considered and approved the issuance of up to 65,00,00,000 equity shares of face value of Rs. 1/- each at a price of Rs.1.66 (including a premium of Rs. 0.66 per equity share) aggregating up to Rs. 107.90 Crore.